Thank you for subscribing!
Learn More about Next Investors - Experts in Biotech Stocks
Next Investors Archived May 31, 2016
When the US Food and Drug Administration (FDA) gives companies its seal of approval, it usually signals the start of a fully endorsed, regulatory-approved push into large commercial markets. No matter what industry a company operates in, FDA product approval is a big milestone.
Next Investors Archived May 25, 2016
Within the next quarter, $12M capped Dimerix (ASX:DXB) is due to publish early results from Phase II clinical trials of its flagship drug therapy DMX-200, a combination therapy designed to alleviate the suffering of people afflicted with Chronic Kidney Disease (CKD).
Next Investors Archived May 04, 2016
We’ve been highlighting the changing landscape in the medical cannabis industry for quite a while. Forgotten for decades, cannabis is coming back as a soft medicine as governments the world over reconsider draconian drug enforcement policy that in hindsight, was throwing the baby out with the bathwater.
Next Investors Archived Apr 20, 2016
As humans continue to live longer, certain diseases start to become more apparent, causing widespread concern for the elderly and their families. One of them is Alzheimer’s disease (AD) – a horrific disease that starts off with short-term memory loss and gradually progresses to severe memory failure including forgetting your own children and family.
Get expert stock analysis direct in your inbox
Next Investors Archived Apr 01, 2016
The market for medical cannabis is gradually moving out of the wilderness and onto government radars. The once forgotten medicine is currently being re-evaluated and reclassified in the US, Australia and Europe as its positive effect on a range of ailments is finally being rediscovered and decriminalised by governments across the globe.
Next Investors Archived Mar 15, 2016
Kidneys are the unsung heroes of our bodies. You may not think about it often, but your healthy kidney keeps your blood pressure regular, filters waste and toxins (i.e. adds water and creates urine), and cleans your blood.
Next Investors Archived Mar 04, 2016
If you haven’t caught the news over the course of the previous week, Australia has moved to make the growth of medical cannabis legal and the medical cannabis commercial industry a reality.
Next Investors Archived Feb 23, 2016
The growth of the medical cannabis industry is gaining momentum. Even doctors are talking more about its use in the treatment of ailments such as skin diseases and in the reduction of pain.
Next Investors Archived Feb 11, 2016
MMJ Phytotech (ASX:MMJ) has put themselves at the front of the queue to start commercialising medical cannabis as and when government officials give the green light.
Join Our Mailing List
